Allergan (AGN) Tops Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St futures rise as AI stocks gain, oil prices slide
- Oil prices slide to 11-day low on hopes of US-Iran diplomacy, Saudi exports
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Anthropic and Accenture partner on embedded AI safety evaluation
Allergan Reports Strong Second Quarter 2016 Continuing Operations Performance with Net Revenues of $3.7 Billion
August 8, 2016 7:00 AM EDTDUBLIN, Aug. 8, 2016 /PRNewswire/ --Â Allergan plc (NYSE: AGN) today reported its second quarter 2016 continuing operations performance.Â
Second Quarter 2016 Continuing Operations
($ in millions, except per share amounts)
Q2 '16
Q2 '15
Q1 '16
Q2 '16v Q2'15
Q2 '16v Q1'16
Total net revenues
$ Â Â 3,684.8
$ Â Â ... More
